Target Malaria hopes to eradicate Africa's malaria-carrying mosquitoes. But when manipulating the fate of a species, moving slowly is a virtue.
A new method looks at the DNA of elephant tusks to pinpoint the crime networks behind disparate stashes of poached ivory.
Napster cofounder Sean Parker and biologist Alex Marson on the coming power of Crispr.
The algorithm can distinguish between different kinds of lung cancer, and could speed up a patient's diagnosis by weeks.
In North Carolina, a nuclear power plant sits right in the hurricane's path, creating a high-stakes test of its post-Fukushima safety measures.
The Crispr-Cas9 intellectual property battle forced scientists to innovate quickly, rendering the expensive, drawn-out legal process nearly irrelevant.
Fearing pseudoscience and privacy breaches, 23andMe is shutting down access to the third-party diet, fitness and other apps that relied on its data.
A new startup, Elevian, is joining a host of other companies trying to disrupt death.
Gene editing halted the progression of Duchenne's muscular dystrophy in dogs
Transcriptome sequencing technologies are opening the doors to a new era of cellular discovery, and not just in the brain.